Related Experiment Video
Updated: Jul 6, 2025

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
Published on: November 21, 2023
Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses
Syamala R Thimmiraju1,2, Jason T Kimata3, Jeroen Pollet1,2
1Department of Pediatrics, Section of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
Pseudoviruses offer a safe and cost-effective method for vaccine development. This platform aids in understanding viral infections and preparing for future outbreaks by simulating virus-receptor interactions.
Area of Science:
- Virology
- Vaccinology
- Infectious Disease Research
Background:
- Pseudoviruses are non-replicating viral particles mimicking native enveloped viruses.
- They serve as a safer and more economical alternative to live viruses in research settings.
Purpose of the Study:
- To educate vaccine developers on pseudovirus technology.
- To outline pseudovirus production methods and their application in assessing vaccine efficacy.
- To highlight their role in simulating emerging viral variants and new viruses.
Main Methods:
- Review of pseudovirus production techniques.
- Discussion of pseudovirus utility in vaccine efficacy studies.
- Exploration of pseudoviruses as wet-lab simulators for viral outbreaks.
Main Results:
- Pseudoviruses enable a better understanding of virus-receptor interactions and entry mechanisms.
- They facilitate preparation for dangerous viral mutations and the development of effective vaccines.
- The platform minimizes the need for high-risk gain-of-function experiments.
Conclusions:
- The pseudovirus platform is a valuable tool for vaccine development against enveloped viruses.
- Familiarity with pseudoviruses is crucial for scientists to mitigate future infectious disease outbreaks.
- This technology supports preparedness for current and emerging viral threats.
More Related Videos
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020